Scarica l'app Stockscreener
27.97
13.38%
-4.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Precedente Chiudi:
$32.29
Aprire:
$31.102
Volume 24 ore:
12.09M
Relative Volume:
3.22
Capitalizzazione di mercato:
$4.55B
Reddito:
$56.99M
Utile/perdita netta:
$-107.23M
Rapporto P/E:
-34.11
EPS:
-0.8199
Flusso di cassa netto:
$-142.55M
1 W Prestazione:
-6.20%
1M Prestazione:
+35.58%
6M Prestazione:
+230.61%
1 anno Prestazione:
+482.71%
Intervallo 1D:
$27.82
$31.68
Intervallo di 1 settimana:
$27.82
$34.39
Portata 52W:
$4.60
$34.39
Tango Therapeutics Inc Stock (TNGX) Company Profile
Nome
Tango Therapeutics Inc
Settore
Industria
Telefono
(857) 320-4900
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Compare TNGX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
27.97 | 4.55B | 56.99M | -107.23M | -142.55M | -0.8199 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-02 | Iniziato | Canaccord Genuity | Buy |
| 2026-02-23 | Iniziato | Mizuho | Outperform |
| 2025-11-18 | Iniziato | Wolfe Research | Peer Perform |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-17 | Iniziato | Jefferies | Buy |
| 2024-04-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Iniziato | Piper Sandler | Overweight |
| 2023-12-08 | Iniziato | B. Riley Securities | Buy |
| 2022-10-20 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Tango Therapeutics Inc (TNGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tango Therapeutics Inc (TNGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tango Therapeutics Inc (TNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tango Therapeutics Inc (TNGX) Institutional Confidence - TradingKey
Tango Therapeutics stock hits all-time high at 33.19 USD By Investing.com - Investing.com Australia
TNGX (Nasdaq: TNGX) affiliate files Form 144 to sell 3.5M shares - Stock Titan
Tango Therapeutics stock hits all-time high at 33.19 USD - Investing.com
Tango Therapeutics Inc (TNGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tango Therapeutics Inc (TNGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tango Therapeutics Inc (TNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Why is Tango Therapeutics stock surging today? By Investing.com - Investing.com Nigeria
symbol__ Stock Quote Price and Forecast - CNN
H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $66 - Moomoo
Tango Therapeutics prices upsized $600M public offering at $30/share - MSN
CCORF Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $42 - Moomoo
[144] Tango Therapeutics, Inc. SEC Filing - Stock Titan
Tango Therapeutics Is Maintained at Buy by Canaccord Genuity - Moomoo
Tango Therapeutics Announces Major Underwritten Equity Offering - TipRanks
Tango Therapeutics Prices $600 Million Stock Offering - Moomoo
A Quick Look at Today's Ratings for Tango Therapeutics(TNGX.US), With a Forecast Between $32 to $66 - Moomoo
Tango Therapeutics Prices $566.5 Million Equity Offering at $30 Per Share; 30-Day Option Granted - TradingView
Tango Therapeutics (NASDAQ: TNGX) prices $566.5M stock and warrant offering - Stock Titan
Tango Therapeutics (TNGX) raises ~$566.5M via 18.17M shares and pre-funded warrants - Stock Titan
Insider sale notice — TNGX (NASDAQ:TNGX) reports planned share sales - Stock Titan
Tango Therapeutics stock price target raised to $66 by H.C. Wainwright on trial data - Investing.com
Tango Therapeutics stock hits all-time high at 32.69 USD By Investing.com - Investing.com India
Is Tango Therapeutics (TNGX) Price Justified After Its 7x Surge In One Year - Yahoo Finance
Tango Therapeutics prices $600 million stock offering - Investing.com India
Tango Therapeutics prices $600 million stock offering By Investing.com - Investing.com India
Tango Therapeutics Announces Pricing of $600 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering - The Manila Times
Tango Therapeutics Expects Gross Proceeds of About $600M From Offering >TNGX - Moomoo
Tango Therapeutics Inc (TNGX) News, Articles, Events & Latest Updates - Stocktwits
H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $66 - Moomoo
Tango Therapeutics launches $500 million stock offering By Investing.com - Investing.com Australia
Tango Therapeutics: Combo Data With Revolution's RAS Inhibitor Whets Risk Appetite (TNGX) - Seeking Alpha
Tango Therapeutics stock rockets 53% on pancreatic cancer data - grafa.com
Tango Therapeutics, American Battery Technology, Intel And Other Big Stocks Moving Higher On Monday - Sahm
TNGX Maintained by HC Wainwright & Co. -- Price Target Raised to $66 - GuruFocus
Tango Therapeutics stock hits all-time high at 32.69 USD - Investing.com
TNGX Stock Jumps 53% on Early Pancreatic Cancer Study Results - Yahoo Finance
TNGX Maintained by Canaccord Genuity -- Price Target Raised to $42 - GuruFocus
Tango Therapeutics stock surges on pancreatic cancer trial data - qz.com
Tango Therapeutics (TNGX) Stock Soars on Pancreatic Cancer Trial Results - Barchart.com
Canaccord raises Tango Therapeutics stock price target on drug combo By Investing.com - Investing.com Nigeria
Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):